Role of endorectal magnetic resonance spectroscopic imaging in two different gleason scores in prostate cancer

Medical Principles and Practice

Volumn 20, Issue 5, 2011, Pages 444-448

  Nagarajan, Rajakumar ^a   Margolis, Daniel ^a   McClure, Tim ^a   Raman, Steve ^a   Thomas, M Albert ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Choline groups; Citrate; Creatine; Magnetic resonance spectroscopic imaging; Prostate cancer

Indexed keywords

CHOLINE; CITRIC ACID; CREATININE;

AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; GLEASON SCORE; HUMAN; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE CANCER; THREE DIMENSIONAL IMAGING;

AGED; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM GRADING; PILOT PROJECTS; PROSTATE; PROSTATIC NEOPLASMS; RECTUM;

EID: 79960494113     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000327675     Document Type: Article

References (25)

1. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 1672-1694.
2. Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT: A preoperative nomogram for disease recurrence following adical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90: 766-771. (Pubitemid 28259189) (Pubitemid 28259189)
3. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626-631.
4. Gleason DF: Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50: 125-128.
5. Bottomley PA: Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508: 333-348.
6. Brown TR, Kincaid BM, Ugurbil K: NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79: 3523-3526. (Pubitemid 12011397) (Pubitemid 12011397)
7. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB: Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38: 311-321. (Pubitemid 27328261) (Pubitemid 27328261)
8. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB: Dual-band spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 2001; 46: 1079-1087. (Pubitemid 33104295) (Pubitemid 33104295)
9. Bostwick DG, Graham SD Jr, Napalkov P, Abrahamsson PA, di Sant'agnese PA, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK: Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 1993; 41: 403-411. (Pubitemid 23146459) (Pubitemid 23146459)
10. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H: Prostate cancer tumor volume: measurement by endorectal MR imaging and MR spectroscopic imaging. Radiology 2002; 223: 91-97. (Pubitemid 34258194) (Pubitemid 34258194)
11. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J: Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999; 213: 473-480. (Pubitemid 29510595) (Pubitemid 29510595)
12. Scheenen TW, Klomp DW, Röll SA, Fütterer JJ, Barentsz JO, Heerschap A: Fast acquisition- weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 2004; 52: 80-88. (Pubitemid 39295259) (Pubitemid 39295259)
13. Zakian KL, Eberhardt S, Hricak H, Shukla- Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA: Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging - initial results. Radiology 2003; 229: 241-247. (Pubitemid 37152131) (Pubitemid 37152131)
14. Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, Scardino PT, Hricak H: Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792. (Pubitemid 43830614) (Pubitemid 43830614)
15. Mescher M, Tannus A, Johnson MO, Garwood M: Solvent suppression using selective echo dephasing. J Magn Reson A 1996; 123: 226-229. (Pubitemid 126752021) (Pubitemid 126752021)
16. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ: Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cm 3 ) spatial resolution. Radiology 1996; 198: 795-805. (Pubitemid 26066301) (Pubitemid 26066301)
17. Hasumi M, Suzuki K, Taketomi A, Matsui H, Yamamoto T, Ito K, Kurokawa K, Aoki J, Endo K, Yamanaka H: The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res 2003; 23: 4223-4227. (Pubitemid 37474924) (Pubitemid 37474924)
18. Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA: Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005; 234: 804-814. (Pubitemid 40250824) (Pubitemid 40250824)
19. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P: Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800-1809.
20. McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and distribution of spread. Am J Surg Pathol 1988; 12: 804-814.
21. Heesters MA, Kamman RL, Mooyaart EL, Go KG: Localized proton spectroscopy of inoperable brain gliomas: response to radiation therapy. J Neurooncol 1993; 17: 27-35. (Pubitemid 24006746) (Pubitemid 24006746)
22. Sijens PE, Knopp MV, Brunetti A, Wicklow K, Alfano B, Bachert P, Sanders JA, Stillman AE, Kett H, Sauter R: 1 H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995; 33: 818-826.
23. Rutter A, Hugenholtz H, Saunders JK, Smith ICP: One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. Invest Radiol 1995; 30: 359-366.
24. Smith TA, Eccles S, Ormerod MG, Tombs AJ, Titley JC, Leach MO: The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer 1991; 64: 821-826.
25. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J: Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003; 50: 944-954. (Pubitemid 37356574) (Pubitemid 37356574)